Muna Therapeutics ApS: Financial statements 2024
CVR: 41142871
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Muna Therapeutics ApS (CVR 41142871) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -124,745,897 and a net result of DKK -173,625,357 compared with DKK -140,319,972 the year before. Equity in the 2024 report amounted to DKK 18,712,811. The solvency ratio was 10.7%. The company had 18 employees in the financial year.
- Gross Profit
- DKK -124,745,897
- Profit/Loss
- DKK -173,625,357
- Equity
- DKK 18,712,811
- Total Assets
- DKK 175,025,974
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -124.7 mio. | -173.6 mio. | 18.7 mio. | 18 |
| 2023 | - | -110.6 mio. | -140.3 mio. | 127 mio. | 18 |
| 2022 | - | -98.2 mio. | -127.7 mio. | 202 mio. | 16 |
| 2021 | - | -49.7 mio. | -61.5 mio. | 162.3 mio. | 7 |
| 2020 | - | -7.3 mio. | -7.4 mio. | 16.7 mio. | 3 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Muna Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -110,624,445, and the net result was DKK -140,319,972.
About Muna Therapeutics ApS
Muna Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Michel Marcel A. Detheux. The board consists of Donald William Nicholson (chair), Camilla Petrycer Hansen, Cillian King and Eileen Elizabeth McGuire. The company's owners include Novo Holdings A/S, Sanofi Foreign Participations B.V. and Axxam S.p.A.. The company has 18 employees (2026). In 2025, the company reported a gross profit of DKK -60,636,000 and a net result of DKK -125,695,000 compared with DKK -173,625,357 the year before. Equity in the 2025 report amounted to DKK -120,338,000.